Miyake Yuka, Tsuzuki Satoshi, Yasumoto Makoto, Fushiki Tohru, Inouye Kuniyo
Laboratory of Enzyme Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto, 606-8502, Japan.
Cytotechnology. 2009 Jul;60(1-3):95. doi: 10.1007/s10616-009-9219-7. Epub 2009 Aug 5.
Hepatocyte growth factor activator inhibitor type I (HAI-1) is a membrane-bound, serine protease inhibitor with two protease-inhibitory domains (Kunitz domain I and II). HAI-1 is known as a physiological inhibitor of a membrane-bound serine protease, matriptase. Paradoxically, however, HAI-1 has been found to be required for the extracellular appearance of the protease in an expression system using a monkey kidney COS-1 cell line. In the present study, we show using COS-1 cells that co-expression of recombinant variants of HAI-1 with the inhibition activity toward matriptase, including a variant consisting only of Kunitz domain I (the domain responsible for inhibition of matriptase), allowed for the appearance of this protease in the conditioned medium, whereas that of the variants without the activity did not. These findings suggest that the inhibition activity toward matriptase is critical for the extracellular appearance of protease in COS-1 cells.
I型肝细胞生长因子激活剂抑制剂(HAI-1)是一种膜结合的丝氨酸蛋白酶抑制剂,具有两个蛋白酶抑制结构域(Kunitz结构域I和II)。HAI-1是一种膜结合丝氨酸蛋白酶——matriptase的生理抑制剂。然而,矛盾的是,在使用猴肾COS-1细胞系的表达系统中,已发现蛋白酶在细胞外的出现需要HAI-1。在本研究中,我们利用COS-1细胞表明,具有对matriptase抑制活性的HAI-1重组变体(包括仅由Kunitz结构域I组成的变体,该结构域负责抑制matriptase)的共表达,使得这种蛋白酶出现在条件培养基中,而无活性的变体则不会。这些发现表明,对matriptase的抑制活性对于COS-1细胞中蛋白酶在细胞外的出现至关重要。